Drug Shortage Report for TARO-BOSENTAN
Report ID | 173499 |
Drug Identification Number | 02483130 |
Brand name | TARO-BOSENTAN |
Common or Proper name | BOSENTAN |
Company Name | TARO PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | BOSENTAN |
Strength(s) | 62.5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 62.5 |
ATC code | C02KX |
ATC description | OTHER ANTIHYPERTENSIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-06-01 |
Estimated end date | 2023-06-30 |
Actual end date | 2023-06-30 |
Shortage status | Resolved |
Updated date | 2023-07-18 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-11-03 | English | Compare |
v2 | 2022-11-03 | French | Compare |
v3 | 2022-11-15 | English | Compare |
v4 | 2022-11-15 | French | Compare |
v5 | 2022-11-24 | English | Compare |
v6 | 2022-11-24 | French | Compare |
v7 | 2022-12-12 | English | Compare |
v8 | 2022-12-12 | French | Compare |
v9 | 2022-12-19 | English | Compare |
v10 | 2022-12-19 | French | Compare |
v11 | 2023-01-10 | English | Compare |
v12 | 2023-01-10 | French | Compare |
v13 | 2023-01-19 | English | Compare |
v14 | 2023-01-19 | French | Compare |
v15 | 2023-02-01 | English | Compare |
v16 | 2023-02-01 | French | Compare |
v17 | 2023-02-10 | English | Compare |
v18 | 2023-02-10 | French | Compare |
v19 | 2023-02-22 | English | Compare |
v20 | 2023-02-22 | French | Compare |